Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert H Slover

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Diabetes Technology & Therapeutics|February 10, 2012
Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE studySatish Garg, Ronald L Brazg, Timothy S Bailey, et al.
Journal of Diabetes Science and Technology|August 6, 2013
ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemiaDavid C Klonoff, Richard M Bergenstal, Satish K Garg, et al.
Diabetes Technology & Therapeutics|January 11, 2014
Hypoglycemia begets hypoglycemia: the order effect in the ASPIRE in-clinic studySatish K Garg, Ronald L Brazg, Timothy S Bailey, et al.
Pediatric Diabetes|June 29, 2017
The dawn of automated insulin delivery: A new clinical framework to conceptualize insulin administrationLaurel H Messer, Gregory P Forlenza, R Paul Wadwa, et al.
Journal of Diabetes Science and Technology|January 10, 2012
The ASPIRE study: design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exercise-induced hypoglycemiaRonald L Brazg, Timothy S Bailey, Satish Garg, et al.
Diabetes Technology & Therapeutics|July 13, 2017
Accuracy of a Fourth-Generation Subcutaneous Continuous Glucose SensorMark P Christiansen, Satish K Garg, Ronald Brazg, et al.
The New England Journal of Medicine|June 25, 2013
Threshold-based insulin-pump interruption for reduction of hypoglycemiaRichard M Bergenstal, David C Klonoff, Satish K Garg, et al.
Diabetes Technology & Therapeutics|August 1, 2018
Accuracy of a Fourth-Generation Continuous Glucose Monitoring System in Children and Adolescents with Type 1 DiabetesRobert H Slover, Jeanie B Tryggestad, Linda A DiMeglio, et al.
Diabetes Technology & Therapeutics|January 31, 2017
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 DiabetesSatish K Garg, Stuart A Weinzimer, William V Tamborlane, et al.
Diabetes Technology & Therapeutics|May 30, 2023
Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 SensorToni L Cordero, Zheng Dai, Arcelia Arrieta, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Diabetes Technology & Therapeutics|February 10, 2012
Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE studySatish Garg, Ronald L Brazg, Timothy S Bailey, et al.
Journal of Diabetes Science and Technology|August 6, 2013
ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemiaDavid C Klonoff, Richard M Bergenstal, Satish K Garg, et al.
Diabetes Technology & Therapeutics|January 11, 2014
Hypoglycemia begets hypoglycemia: the order effect in the ASPIRE in-clinic studySatish K Garg, Ronald L Brazg, Timothy S Bailey, et al.
Pediatric Diabetes|June 29, 2017
The dawn of automated insulin delivery: A new clinical framework to conceptualize insulin administrationLaurel H Messer, Gregory P Forlenza, R Paul Wadwa, et al.
Journal of Diabetes Science and Technology|January 10, 2012
The ASPIRE study: design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exercise-induced hypoglycemiaRonald L Brazg, Timothy S Bailey, Satish Garg, et al.
Diabetes Technology & Therapeutics|July 13, 2017
Accuracy of a Fourth-Generation Subcutaneous Continuous Glucose SensorMark P Christiansen, Satish K Garg, Ronald Brazg, et al.
The New England Journal of Medicine|June 25, 2013
Threshold-based insulin-pump interruption for reduction of hypoglycemiaRichard M Bergenstal, David C Klonoff, Satish K Garg, et al.
Diabetes Technology & Therapeutics|August 1, 2018
Accuracy of a Fourth-Generation Continuous Glucose Monitoring System in Children and Adolescents with Type 1 DiabetesRobert H Slover, Jeanie B Tryggestad, Linda A DiMeglio, et al.
Diabetes Technology & Therapeutics|January 31, 2017
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 DiabetesSatish K Garg, Stuart A Weinzimer, William V Tamborlane, et al.
Diabetes Technology & Therapeutics|May 30, 2023
Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 SensorToni L Cordero, Zheng Dai, Arcelia Arrieta, et al.
Pageof 3